Nipah virus confirmed in India: first cases since 2026 and prevention measures
The reappearance of the Nipah virus in India at the beginning of 2026 has brought back into focus one of the most dangerous known zoonotic pathogens. Although the number of cases remains limited, health authorities in several Asian countries have intensified border controls and epidemiological surveillance measures, especially for passengers arriving from the affected areas.
The Nipah virus is not new, but the severity of the disease it causes and its high mortality rate explain why every outbreak attracts the attention of the international medical community. However, specialists emphasize that in its current form, the risk of a global spread is low.
Table of Contents
- What is the Nipah virus?
- Current situation in Asia
- How the virus is transmitted
- Symptoms and progression of the disease
- What is the risk for travelers
- Basic prevention recommendations
- Diagnosis and treatment
What is the Nipah virus
Nipah is a zoonotic virus, meaning it is transmitted from animals to humans. Its natural reservoir is fruit bats, also known as "flying foxes." In certain contexts, pigs can become intermediate hosts, facilitating the transmission of the virus to humans.
Nipah infection was first identified in the late 1990s in Malaysia, where it caused a major outbreak among pig farmers. Since then, sporadic episodes have been reported in India and Bangladesh, some associated with limited human-to-human transmission.
Current situation in Asia
At the beginning of 2026, Indian authorities confirmed several cases of Nipah virus infection in the state of West Bengal, including among medical staff. Dozens of people who came into contact with confirmed patients are being monitored or are in quarantine.
As a precautionary measure, countries such as Thailand, Nepal, and Taiwan have introduced additional health screenings for passengers arriving from the affected regions. In parallel, some states are considering tightening the reporting protocol for suspected cases to allow for rapid intervention in the event of new outbreaks.
How the virus is transmitted
Transmission of the Nipah virus occurs through direct contact, not through the air over long distances, which limits the potential for rapid spread. Humans can become infected following contact with infected animals, especially fruit bats or pigs, or by consuming contaminated food, such as fruit or raw palm sap.
In certain situations, the virus can also be transmitted from human to human through close contact with respiratory secretions or other bodily fluids. This type of transmission has been documented especially within families and in medical settings, in the absence of adequate protective measures.
Symptoms and progression of the disease
Nipah virus infection usually begins with non-specific symptoms such as fever, headache, muscle pain, cough, or vomiting. In some cases, the disease can rapidly progress to severe forms characterized by breathing difficulties and inflammation of the brain, known as encephalitis.
Severe forms can lead to seizures, altered consciousness, and coma, sometimes within 24–48 hours. The mortality rate reported in previous outbreaks has ranged between 40% and 75%, depending on the viral strain and the medical system's ability to intervene quickly.
What is the risk for travelers
For most travelers, the risk of infection remains low. There is no evidence of widespread community transmission outside the affected areas in India, and countries in the region have not reported local cases.
The risk is higher for individuals traveling to areas with active outbreaks or who come into direct contact with wild animals, sick farm animals, or infected people.
Basic prevention recommendations
Specialists recommend avoiding contact with bats and wild animals, as well as the consumption of fallen fruit or food products that could be contaminated. Rigorous hand hygiene and avoiding contact with the bodily fluids of sick individuals remain essential measures.
People returning from affected areas are advised to monitor their health for two to three weeks and to contact a doctor if any symptoms appear, mentioning their recent travel history.
Diagnosis and treatment
Diagnosis of Nipah virus infection is made through specialized laboratory tests, primarily using PCR molecular methods. Currently, there is no specific antiviral treatment or licensed vaccine against this virus. Patient care is supportive and focuses on treating respiratory and neurological complications.
The Nipah virus represents a serious threat in areas where outbreaks occur, but there are no indications at this time that it could trigger a global health crisis. For the general public and most travelers, the risk is low, and proper information and adherence to prevention measures remain the most effective methods of protection.
References:
- World Health Organization (WHO). Nipah virus infection. https://www.who.int/health-topics/nipah-virus-infection
- Centers for Disease Control and Prevention (CDC). About Nipah Virus. https://www.cdc.gov/nipah-virus/about/index.html
- Communicable Diseases Agency (CDA), Singapore Government. Nipah virus infection. https://www.cda.gov.sg/professionals/diseases/nipah-virus-infection/
- BBC News. Nipah virus: Some Asia airports screen passengers after outbreak in India. https://www.bbc.com/news/articles/cd7zp581q5do
- Hyatt, A. D. et al. Electron micrographs of Vero cells infected with Nipah virus – Figure 3. ResearchGate. https://www.researchgate.net/figure/Electron-micrographs-of-Vero-cells-infected-with-Nipah-virus-Figure-3a-was-captured-from_fig3_23173095
Photo source: Freepik
